VC-Verzeichnis

Europäisches VC-Verzeichnis

Kuratierter Index aktiver Venture-Capital-Fonds in Europa und Israel. Verfolge Investoren, Phasen und Ticketgrößen.

Lone Pine Capital

USA

Lone Pine Capital is a research-driven fundamental equity investment firm serving global partners. Their approach combines enduring methods, dynamic change, and purposeful collaboration. They integrate cross-sectional research, deep diligence, and diverse perspectives to identify high-conviction ideas aiming for outsized outcomes for their investors. Their investment philosophy emphasizes comprehensive research, both qualitative and quantitative, encompassing macro and micro perspectives, long and short positions, and public and private markets. This research method integrates various factors into a feedback loop of learning, innovation, and optimization, fueling continuous pursuit of compelling risk-reward opportunities worldwide that meet their rigorous investment criteria. They prioritize long-lasting relationships with clients to achieve mutual growth, remaining rooted in people, performance, and service, leveraging deep expertise, innovation, and enduring partnerships.

Public and Private MarketsPublic EquityPrivate Equity

Longevity Science Foundation

Zug, CH

Advancing scientific breakthroughs to extend human lifespan and healthspan through funding of research projects and academic collaborations.

Research grants and academic partnershipsFundamental research on healthy aging and longevity

Longwall Venture Partners

Großbritannien

Longwall Ventures invests in highly theoretical, pre-market-fit deep tech startups that require patient capital and technical fluency to scale from prototype to global business. They focus on complex challenges in advanced manufacturing, life sciences, defence, and clean energy, providing hands-on, collaborative support to build enduring businesses.

Pre-seed to Series AEarly-stage deep tech ventures with strong scientific foundations

Longwall Ventures

Großbritannien

Longwall Ventures backs patient capital-intensive deep tech ventures where great science requires time and technical fluency to reach market readiness. They specialize in sectors like life sciences, physical sciences, advanced manufacturing, defence, and clean energy, focusing on complex challenges that demand long-term, hands-on investment and collaboration.

Early-stage (pre-market-fit to product launch)Early-stage deep tech companies transforming UK research into global businessesfocusing on high-risk

Lugus Capital

Dublin, IE

Lugus Capital is an Irish-based real estate investment platform offering strategic insights, data-driven analysis, and innovative thinking to deliver exceptional returns and enhance the built environment.

Not mentionedReal estate investmentdevelopment

Lumaux

Niederlande
L

Lumaux is an Eindhoven-based seed fund that invests in Dutch deep technology companies.

SeedDeep Tech

Luminous Ventures

London, Großbritannien

Investing in early-stage companies leveraging cutting-edge science and technology to address global challenges, particularly in healthcare and life sciences.

Seed and Series ADeep Tech with a focus on the application of innovative technologies to healthcare & life sciences

Lumira Ventures

Toronto, CA

Lumira Ventures invests in groundbreaking healthcare solutions across North America, focusing on life sciences innovations that address unmet medical needs, particularly in biotech, biotherapeutics, and medical devices.

Early-stage to revenue-generatingEarly-stage to revenue-generating healthcare innovatorsincluding biotech

Lumière AI Ventures

CA

Lumiere provides AI-powered video intelligence and audience insights to help brands, creators, and platforms measure engagement, analyze content performance, and optimize interactive experiences through deep content analytics.

Pre-SeedVideo analyticsaudience insights

Lundbeckfond Invest

DK

Invests in high-quality companies with strong leadership, high profitability, good cash flow, healthy balance sheets, and a persistent competitive edge to enable long-term growth in earnings and value creation. Focuses on diversification across sectors and asset classes to reduce risk. Approximately 33% of assets are managed externally, with partnerships for specific investments (e.g., property).

Not explicitly mentioned, but seems to focus on established companies with long-term ownership potential and biotech companiesLiquid sharesbonds

Lundbeckfonden BioCapital

DK

SNIPR Biome leverages CRISPR-Cas technology to develop microbial medicines for precision killing of bacteria and gene modification, addressing critical infectious diseases like antibiotic-resistant infections in cystic fibrosis and hematologic cancers. The company focuses on selective, ultra-rapid bacterial eradication while preserving the patient’s microbiome, with a pipeline targeting pathogens of high importance, including Pseudomonas aeruginosa and antibiotic-resistant bacteria.

Clinical-StageCRISPR-based microbial interventionsprecision killing of bacteria

Luno

Großbritannien

Luno focuses on building Future-Grade Finance™ by enabling regulated access to cryptocurrencies, tokenized stocks, and global payments infrastructure. Their platform supports embedded crypto solutions for banks and telcos, fractional ownership of assets, and cross-border stablecoin transactions.

UnclearCrypto infrastructureregulated digital asset platforms

Lux Media Investments

Luxembourg, LU

Lux Media Investments focuses on media and technology investments that combine principal protection with high-growth opportunities. The firm targets scalable, disruptive enterprises with scalable business models, aiming to deliver both social impact and sustainable financial returns. Investments prioritize companies with global potential, led by visionary leaders, and are structured to balance stability (via fixed-income) with transformative growth potential.

Growth-stage companies poised for IPOs or strategic acquisitionsPrincipal-protected structured notesscalable media/tech enterprises

Lynx Financial (HK) Limited

Shanghai, CN

Lynx Financial connects life science innovators across China, the U.S., and Europe with capital and strategic partners, leveraging a team of physicians, scientists, and investors to accelerate medical technologies to patients globally.

Seed to Series A (equity investment) + cross-border advisory (inbound/outbound).Cross-border healthcare innovation (pharmadiagnostics

M Ventures (Merck)

Darmstadt, Deutschland

Invests in visionary companies that develop transformative solutions in healthcare drug development, life science tools, electronics, and sustainability, with a dual strategic and financial focus. Supports entrepreneurs with active involvement in portfolio companies to drive commercial success.

Series ABiotechnology and Technologyincluding Healthcare drug development

M-Venture

Deutschland

Provides hands-on guidance for startups and businesses across the entire lifecycle—from ideation and execution (Start/Build) to crisis management (Fix) and maximizing exit value (Sell). Focuses on strategic planning, execution, and operational resilience, leveraging Howard Thaw’s 25+ years of entrepreneurial, medical, and tech industry experience.

M1 Capital

M

M1 Capital specializes in structuring and executing transactions for commodity traders, producers, and infrastructure owners, focusing on working capital facilities, trade finance, and M&A in mining, energy, petrochemicals, and soft commodities. Their expertise spans cross-border deals, asset-backed financing, and deal lifecycle management in complex international environments.

Transaction execution and advisory (not early-stage investment)Advisory services for commodity trade financecapital raising

M12 Microsoft’s Venture Fund

M

M12 is Microsoft’s venture capital fund. It invests in companies from seed through Series B, including enterprise software and foundational technology.

Seed to Series BEnterprise TechnologyDeep Tech

M1720

M

M1720 is a venture fund that backs US technology companies at seed and Series A.

Seed and Series ATechnology

M2care

CH

M2CARE is a venture studio investing in, operating, and developing healthtech innovations to address critical health challenges. They test feasibility, create startups from innovations, provide capital, operational support, and accelerate market access for projects.

Seed to Series AHealth innovations addressing major health challenges (e.g.retinal therapy

MAIF Impact

Paris, Frankreich

MAIF Impact invests in innovative businesses whose models generate positive social, societal, or environmental outcomes.

Startups et entreprises matures (créées depuis plus de 2 ans) en levée de fonds (montant minimal d'1M€)socially innovative businesses with positive social and environmental impact

MBG H Mittelständische Beteiligungsgesellschaft Hessen

Wiesbaden, Deutschland

MBG Hessen provides equity and mezzanine financing to small businesses and founders in Hessen, including support for investment and growth.

Early-stage (Mikromezzanin), Wachstumsphase (Kleinbeteiligungen, Wachstumsfinanzierung), UnternehmensnachfolgeSmall businesses and founders

MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg

Deutschland

MBG Baden-Württemberg fördert als unabhängiger, bankenunabhängiger Finanzierungspartner innovative Start-ups, Wachstumsunternehmen und Unternehmensnachfolgen in Baden-Württemberg. Durch stille und offene Beteiligungen sowie Mezzanine-Kapital unterstützt die MBG langfristige Finanzierungslösungen, die Unternehmen handlungsfähig halten und Krisenresilienz stärken. Die tiefe Vernetzung mit Verbänden, Kammern und Beratern beschleunigt das Wachstum der Portfoliounternehmen durch Zugang zu Expertise und Netzwerkressourcen.

Early-stage bis etablierte Mittelständler (Gründungen, Wachstum, Nachfolge)Innovative Start-upsWachstums- und Innovationsvorhaben

MBG Mittelständische Beteiligungsgesellschaft Schleswig-Holstein mbH

Kiel, Deutschland

MBG Schleswig-Holstein provides participation and mezzanine financing for startups and small and medium-sized businesses in Schleswig-Holstein.

Start-Ups, kleine Unternehmen, Mittelstand (verschiedene Entwicklungsphasen)Startups and small and medium-sized businesses